LEGIONELLA TESTING MARKET ANALYSIS

Legionella Testing Market, By Test Type (Culture Method, Urinary Antigen Test (UAT), Direct Fluoroscent Antibody (DFA) Test, Polymerase Chain Reaction (PCR), Other Test Types), By Sample Type (Water, Biofilm, Swab Samples), By Application (Clinical Testing Method and Environmental Testing Method), By End User (Hospital, Clinics, Diagnostics Laboratory, Water Treatment Industries), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Recent Developments

New service launches/ grants

In June 2022, Eurofins J3 Resources, part of Eurofins Built Environment Testing U.S., specializing in a full suite of analyses including asbestos, Legionella, etc., announced it had granted AIHA LAP, LLC accreditation as part of a national expansion program of industrial hygiene credentials.
In May 2022, ChemREADY, a manufacturer of water and wastewater treatment chemicals, announced the debut of its new Legionella testing services and product line to battle the water-borne infection in building water systems.
In August 2020, IDEXX, a global leader in pet healthcare innovation, announced that the Legiolert culture testing method for Legionella pneumophila (L. pneumophila) has been accepted by the UK’s Standing Committee of Analysts (SCA).

Acquisition and partnerships

In August 2022, Canadian firm Genomadix entered into a collaboration with the Mayo Clinic, a healthcare company, to advance its point-of-care molecular analyzer technology.
In June 2022, the New York Attorney General, Verizon, and the New York Attorney General signed an agreement that requires Verizon to act quickly and thoroughly to prevent the Legionnaires' illness from spreading throughout the state of New York.
In December 2021, Pace Analytical Services, a division of Pace Science and Technology Company and preferred provider of in-lab, mobile, and emergency onsite specialty-contaminant and regulatory testing and analysis services, announced that it had acquired Special Pathogens Laboratory, the market leader in Legionella testing, detection, remediation, and prevention. This acquisition aims to strengthen testing and analytical capabilities for Legionnaires' disease.